Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Active Rheumatoid Arthritis”

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06245408
What this trial is testing

A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State

Who this might be right for
Sjögren's Syndrome (SS)
Amgen 434
Large-scale testing (Phase 3)Study completedNCT02744755
What this trial is testing

Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Sandoz 353
Not applicableStudy completedNCT05323591
What this trial is testing

Prospective Observational Study of Filgotinib in Participants With Rheumatoid Arthritis in France

Who this might be right for
Rheumatoid Arthritis
Alfasigma S.p.A. 155
Large-scale testing (Phase 3)Study completedNCT03052322
What this trial is testing

MSB11022 in Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Moderate to Severe Rheumatoid Arthritis
Fresenius Kabi SwissBioSim GmbH 288
Testing effectiveness (Phase 2)Study completedNCT05460832
What this trial is testing

Phase 2b Study of MBS2320 in Participants With Methotrexate-Refractory RA

Who this might be right for
Rheumatoid Arthritis
Modern Biosciences Ltd 248
Testing effectiveness (Phase 2)WithdrawnNCT02795299
What this trial is testing

Study Evaluating Gerilimzumab´s Safety/Efficacy for Patients MTX or TNFα Antagonist Failed in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bird Rock Bio, Inc.
Large-scale testing (Phase 3)UnknownNCT05725434
What this trial is testing

Evaluate Usability of Subcutaneous Auto-injector of CT-P47 in Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Celltrion 30
Testing effectiveness (Phase 2)Ended earlyNCT04888585
What this trial is testing

Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 473
Large-scale testing (Phase 3)Active Not RecruitingNCT02629159
What this trial is testing

A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
AbbVie 1,629
Testing effectiveness (Phase 2)Looking for participantsNCT06972446
What this trial is testing

Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
AbbVie 180
Large-scale testing (Phase 3)Study completedNCT01711359
What this trial is testing

A Study in Participants With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 588
Large-scale testing (Phase 3)Study completedNCT02265705
What this trial is testing

Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 290
Not applicableStudy completedNCT03387423
What this trial is testing

Observational Study to Determine How Physicians Make Treatment Decisions in Patients Treated With Tofacitinib for Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Pfizer 1,459
Testing effectiveness (Phase 2)Study completedNCT07335952
What this trial is testing

Proximod, a Selective Sphingosine-1-phosphate Receptor 1 Modulator in Patients With Moderate-to-severe Active Rheumatoid Arthritis: a Double-blind, Randomised, Placebo-controlled, Phase 2 Trial.

Who this might be right for
Rheumatoid Arthritis
Peking University People's Hospital 179
Testing effectiveness (Phase 2)Study completedNCT01894516
What this trial is testing

Dose-finding Study of GLPG0634 as Monotherapy in Active Rheumatoid Arthritis (RA) Participants (DARWIN2)

Who this might be right for
Rheumatoid Arthritis
Lakefront Biotherapeutics NV 287
Not applicableEnded earlyNCT01464021
What this trial is testing

A Post-Marketing Observational Study to Evaluate the Effectiveness of Adalimumab in Patients With Moderately to Severely Active Rheumatoid Arthritis in China

Who this might be right for
ArthritisRheumatoid
AbbVie (prior sponsor, Abbott) 26
Large-scale testing (Phase 3)Study completedNCT01232569
What this trial is testing

RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 656
Testing effectiveness (Phase 2)Study completedNCT03813199
What this trial is testing

Study of Two Doses of ABX464 in Participants With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Abivax S.A. 60
Post-approval studies (Phase 4)Study completedNCT01010503
What this trial is testing

Tocilizumab With or Without Methotrexate in Patients With Rheumatoid Arthritis.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 32
Post-approval studies (Phase 4)Study completedNCT00996203
What this trial is testing

Tocilizumab Added to DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to DMARDs.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 201
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation